BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Noha G. Bader El Din, Sally Farouk, Reem El-Shenawy, Mostafa M. Elhady, Marwa K. Ibrahim, Reham M. Dawood, Ahmed M. Salem, Mostafa K. El Awady. The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 PatientsViral Immunology 2017; 30(2): 127 doi: 10.1089/vim.2016.0083
2
Antonino Tuttolomondo, Domenico Di Raimondo, Chiara Bellia, Giuseppe Clemente, Rosaria Pecoraro, Carlo Maida, Irene Simonetta, Valerio Vassallo, Danilo Di Bona, Eliana Gulotta, Marcello Ciaccio, Antonio Pinto, Jose Ignacio Herrero. Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory AscitesPLOS ONE 2016; 11(12): e0165443 doi: 10.1371/journal.pone.0165443
3
Abdel-Rahman N Zekri, Hanaa M Alam El-Din, Abeer A Bahnassy, Naglaa A Zayed, Waleed S Mohamed, Suzan H El-Masry, Sayed K Gouda, Gamal Esmat. Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4Comparative Hepatology 2010; 9(1) doi: 10.1186/1476-5926-9-1
4
Cosimo Marcello Bruno, Maria Valenti, Gaetano Bertino, Annalisa Ardiri, Alfredo Amoroso, Maria Consolo, Clorinda Maria Mazzarino, Sergio Neri. Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitisAnnals of Saudi Medicine 2011; 31(4): 360 doi: 10.4103/0256-4947.83215
5
Mohamed I. Radwan, Heba F. Pasha, Rasha H. Mohamed, Hala I.M. Hussien, Mohamed N. El-Khshab. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patientsCytokine 2012; 60(1): 271 doi: 10.1016/j.cyto.2012.05.010
6
Ahmed Babiker, Mohamed Hassan, Safwan Muhammed, Gregory Taylor, Bhawna Poonia, Anoop Shah, Shashwatee Bagchi. Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A reviewClinical Cardiology 2020; 43(3): 222 doi: 10.1002/clc.23299
7
Mohamed El-Shahat Ebeid, Kadry Abdel-Kader El-Bakry. Cellular immune response to infection by different genotypes of hepatitis C virusIndian Journal of Clinical Biochemistry 2009; 24(3): 234 doi: 10.1007/s12291-009-0044-8
8
Manuela G. Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, Marc Bourliere, Patrick Marcellin, Cristhian Trepo, Tony Mazulli, George Moussa, Ankit Patel, Asad A. Baig, Lawrence Cohen. Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis CInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/231210
9
T Motawi, OG Shaker, RM Hussein, M Houssen. Polymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infectionBalkan Journal of Medical Genetics 2016; 19(2): 35 doi: 10.1515/bjmg-2016-0034
10
Hala O. El-Mesallamy, Nadia M. Hamdy, Hanan H. Rizk, Abdel-Rahman El-Zayadi. Apelin Serum Level in Egyptian Patients with Chronic Hepatitis CMediators of Inflammation 2011; 2011: 1 doi: 10.1155/2011/703031
11
Chun-che Lin, Mei-chin Yin. Clinical significance of circulating IL-10 and fibronectin levels in hepatocellular carcinoma patients with HBV infectionBioMedicine 2012; 2(3): 122 doi: 10.1016/j.biomed.2012.06.003
12
Rosario González-Casas, María Trapero-Marugán, Ricardo Moreno-Otero. Hepatitis crónica por virus de la hepatitis C genotipo 4Medicina Clínica 2011; 137(1): 31 doi: 10.1016/j.medcli.2010.03.022
13
Abdel-Rahman N Zekri, Abeer A Bahnassy, Waleed S Mohamed, Hanaa M Alam EL-Din, Hend I Shousha, Naglaa Zayed, Dina H Eldahshan, Ashraf Omar Abdel-Aziz. Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by InterferonVirology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-218
14
Cho Naing, Joon Wah Mak, Nyunt Wai, Mala Maung. Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?Current Diabetes Reports 2013; 13(3): 428 doi: 10.1007/s11892-013-0370-3
15
Barbara Roe, William W. Hall. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virusExpert Reviews in Molecular Medicine 2008; 10 doi: 10.1017/S1462399408000847
16
Zakaria Y. Mohran, Fatma A. Ali-Eldin, Hala A. Abdel Aal. Serum interleukin-18: Does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?Arab Journal of Gastroenterology 2011; 12(1): 29 doi: 10.1016/j.ajg.2010.11.002
17
A. R. N. Zekri, H. A. Haleem, G. E. -D. Esmat, A. A. Bahnassy, H. M. A. El-Din, M. M. Hafez, A. F. Sharaby, H. Sharaf, M. S. E.-D. Zakaria. Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4Journal of Viral Hepatitis 2007; 14(7): 468 doi: 10.1111/j.1365-2893.2006.00832.x
18
Hoda Mohamed El-Emshaty, Wesam Ahmad Nasif, Ibrahim Eldsoky Mohamed. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory ResponseDisease Markers 2015; 2015: 1 doi: 10.1155/2015/707254
19
Mohamed Elashri, Farag M. Farag, Nader El-Malky, Elsayed Abd Elmaksood, Mohammed Elarman. Serum level of interleukin-8 and interleukin-10 as predictors for response to interferon–ribavirin combined therapyEgyptian Liver Journal 2016; 6(1): 7 doi: 10.1097/01.ELX.0000481902.94221.61
20
Vikas Verma, Anita Chakravarti, Premashis Kar. Cytokine Levels of TGF-β, IL-10, and sTNFαRII in Type C Chronic Liver DiseaseDigestive Diseases and Sciences 2008; 53(8): 2233 doi: 10.1007/s10620-007-0130-9
21
Anuradha Budhu, Xin Wei Wang. The role of cytokines in hepatocellular carcinomaJournal of Leukocyte Biology 2006; 80(6): 1197 doi: 10.1189/jlb.0506297
22
Moana Gelu-Simeon, Didier Samuel. Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinomaHepatology International 2013; 7(3): 788 doi: 10.1007/s12072-013-9441-4
23
Jinhwa Lee. Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular CarcinomaThe Korean Journal of Physiology & Pharmacology 2013; 17(5): 375 doi: 10.4196/kjpp.2013.17.5.375
24
Manuela G. Neuman, Kristi K. McKinney, Radu M. Nanau, Vincent Kong, Izabella Malkiewicz, Tony Mazulli, George Moussa, Lawrence B. Cohen. Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivationTranslational Research 2013; 161(5): 430 doi: 10.1016/j.trsl.2012.12.012
25
Jingkun Liu, Linbang Wang, Wenjun Wang, Yaping Li, Xiaoli Jia, Song Zhai, Juan Shi, Shuangsuo Dang. Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virusMolecular Medicine Reports 2016; 14(3): 2379 doi: 10.3892/mmr.2016.5527
26
Shallu Tomer, Yogesh K Chawla, Ajay Duseja, Sunil K Arora. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infectionWorld Journal of Gastroenterology 2016; 22(22): 5173-5182 doi: 10.3748/wjg.v22.i22.5173
27
Soheil Tavakolpour, Shahnaz Sali. Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-AnalysisHepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.33537
28
Abdel-Rahman N Zekri, Abeer A Bahnassy, Sabrin A Abdel-Wahab, Medhat M Khafagy, Samah A Loutfy, Hessam Radwan, Sabry M Shaarawy. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4Journal of Gastroenterology and Hepatology 2009; 24(3): 416 doi: 10.1111/j.1440-1746.2008.05699.x
29
Giuseppe Castello, Stefania Scala, Giuseppe Palmieri, Steven A. Curley, Francesco Izzo. HCV-related hepatocellular carcinoma: From chronic inflammation to cancerClinical Immunology 2010; 134(3): 237 doi: 10.1016/j.clim.2009.10.007
30
Mohamed S. Othman, Ahmed M. Aref, Amal A. Mohamed, Wesam A. Ibrahim. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian PatientsISRN Hepatology 2013; 2013: 1 doi: 10.1155/2013/412317
31
Daniel Fuster, Judith I. Tsui, Debbie M. Cheng, Emily K. Quinn, Kaku A. Armah, David Nunes, Matthew S. Freiberg, Jeffrey H. Samet. Interleukin-6 Is Associated with Noninvasive Markers of Liver Fibrosis in HIV-Infected Patients with Alcohol ProblemsAIDS Research and Human Retroviruses 2013; 29(8): 1110 doi: 10.1089/aid.2012.0348
32
Ajax M. Atta, Isabela S. Oliveira, Gabriel M. Sousa, Raymundo Paraná, Maria L. Sousa Atta. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodiesMicrobial Pathogenesis 2010; 48(2): 53 doi: 10.1016/j.micpath.2009.12.002
33
Esmail Mohamad El-Fakharany, Nawal Abd El-Baky, Mustafa Hassan Linjawi, Abdullah Abdelhafiz Aljaddawi, Tahya Hussein Saleem, Ahmed Yassine Nassar, Ashraf Osman, Elrashdy Moustafa Redwan. Influence of camel milk on the hepatitis C virus burden of infected patientsExperimental and Therapeutic Medicine 2017; 13(4): 1313 doi: 10.3892/etm.2017.4159
34
Abdel-Rahman Nabawy Zekri, Amira Salah El-Din Youssef, Yasser Mabrouk Bakr, Reham Mohamed Gabr, Ola Sayed Ahmed, Mostafa Hamed Elberry, Ahmed Mahmoud Mayla, Mohamed Abouelhoda, Abeer A Bahnassy. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical modelWorld Journal of Gastroenterology 2016; 22(16): 4168-4182 doi: 10.3748/wjg.v22.i16.4168